Kancera Ab Stock Price To Earning
| KAN Stock | SEK 1.52 0.09 6.29% |
Kancera AB fundamentals help investors to digest information that contributes to Kancera AB's financial success or failures. It also enables traders to predict the movement of Kancera Stock. The fundamental analysis module provides a way to measure Kancera AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kancera AB stock.
Kancera |
Kancera AB Company Price To Earning Analysis
Kancera AB's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Kancera AB Price To Earning | (11.64) X |
Most of Kancera AB's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kancera AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Kancera AB has a Price To Earning of -11.64 times. This is 145.05% lower than that of the Healthcare sector and notably lower than that of the Biotechnology industry. The price to earning for all Sweden stocks is 140.53% higher than that of the company.
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Kancera Fundamentals
| Return On Equity | -0.47 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (72.39) % | |||
| Current Valuation | 14.76 M | |||
| Shares Outstanding | 79.53 M | |||
| Shares Owned By Insiders | 13.72 % | |||
| Shares Owned By Institutions | 2.86 % | |||
| Price To Earning | (11.64) X | |||
| Price To Book | 1.44 X | |||
| Price To Sales | 168.19 X | |||
| Revenue | 1.7 M | |||
| Gross Profit | 1.7 M | |||
| EBITDA | (45.35 M) | |||
| Net Income | (45.69 M) | |||
| Cash And Equivalents | 106.52 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 442 K | |||
| Debt To Equity | 33.30 % | |||
| Current Ratio | 2.11 X | |||
| Book Value Per Share | 1.50 X | |||
| Cash Flow From Operations | (44.12 M) | |||
| Earnings Per Share | (0.87) X | |||
| Target Price | 1.6 | |||
| Beta | 1.28 | |||
| Market Capitalization | 262.69 M | |||
| Total Asset | 133.64 M | |||
| Working Capital | 11 M | |||
| Current Asset | 16 M | |||
| Current Liabilities | 5 M | |||
| Net Asset | 133.64 M |
About Kancera AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kancera AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kancera AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kancera AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kancera AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Kancera Stock analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |